Skip to main content
IBXG logo

iBX Group, Inc. (IBXG) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.00001 $0.00 (0.00%)
Vol: 2.0K| 52-wk range: $0.000001 – $0.00001
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

iBX Group, Inc. (IBXG) trades at $0.00001. Sector: Healthcare.

Price as of · Last analyzed: Jun 15, 2026
iBX Group, Inc. provides comprehensive administrative and technical support services primarily to healthcare clients across the United States, operating through its Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR) segments. The company's offerings range from physician practice management and billing to multi-specialty clinics and software application development.

Analyst Coverage for IBXG: IBXG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the IBXG film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

iBX Group, Inc. (IBXG) Healthcare & Pipeline Overview

CEOYoshiko Tomori Shale
Employees47
HeadquartersDeerfield Beach, US
IPO Year2002

iBX Group, Inc. is a U.S.-based healthcare services provider, specializing in administrative, technological, and rehabilitative support for medical clients. The company leverages its dual HTMT and PTR segments to offer a broad spectrum of solutions, from practice management and billing to physical therapy and software development, positioning itself within the evolving healthcare support market.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for IBXG?

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

iBX Group, Inc. operates within the growing U.S. healthcare support services market, offering a diversified portfolio across administrative technology and direct rehabilitation services. The company's dual focus on Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR) services positions it to capitalize on increasing demand for outsourced administrative efficiency and specialized patient care. Key value drivers include the ongoing need for streamlined physician practice management, robust billing solutions, and advanced healthcare IT, alongside demographic trends supporting growth in physical therapy and wellness programs. The company's established presence since 1997 and its comprehensive service offerings provide a foundation for potential client acquisition and retention. However, the investment thesis must also acknowledge significant challenges, including a reported negative gross margin of -164.0% and its listing on the OTC Other market, which implies limited liquidity and heightened volatility. Future growth will depend on the company's ability to achieve operational efficiencies, improve profitability, and navigate the complexities of the OTC market while expanding its service reach and client base.

Based on FMP financials and quantitative analysis

IBXG Key Highlights

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

iBX Group, Inc. operates with a negative gross margin of -164.0%, indicating that the cost of goods sold significantly exceeds revenue.

  • The company maintains a small operational footprint with 47 employees, suggesting a lean organizational structure for its dual service segments.
  • With a market capitalization of $0.00 billion, iBX Group, Inc. is classified as a micro-cap entity, reflecting its nascent stage or limited market valuation.
  • The company's Free Cash Flow (FCF) is reported at $-0.00 billion, indicating that it is not generating positive cash from its operations after capital expenditures.
  • iBX Group, Inc. trades on the OTC Other market, signifying a lower tier of over-the-counter trading with potentially less stringent disclosure requirements and limited liquidity.

Who Are IBXG's Competitors?

IBXG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
SCNX Scienture Holdings, Inc. $3.71 -6.55% $6.03M —
ACON Aclarion, Inc. $2.31 -1.50% $6.64M —
MGRX Mangoceuticals, Inc. $0.44 +4.67% $7.42M —
BFRG Bullfrog AI Holdings, Inc. Common Stock $0.59 -3.81% $11.0M —
ONMD OneMedNet Corporation $4.97 -2.74% $28.3M —
BEAT HeartBeam, Inc. $0.57 -12.44% $31.8M 30 5-pillar
EUDA EUDA Health Holdings Limited $19.38 +12.02% $36.2M —
CCLD CareCloud, Inc. $2.06 +0.74% $87.3M 68 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are IBXG's Key Strengths?

Diversified service offering across administrative/technology (HTMT) and direct patient care (PTR) segments.

  • Specialized focus on the U.S. healthcare sector, allowing for deep industry expertise.
  • Established operational history since 1997, indicating experience and market presence.
  • Capability to develop custom software applications, offering potential for proprietary solutions.

What Are IBXG's Weaknesses?

Reported negative gross margin of -164.0%, indicating significant operational inefficiencies or pricing challenges.

  • Small employee base of 47, which may limit scalability and capacity for large-scale projects.
  • Listing on the OTC Other market, associated with limited liquidity, heightened volatility, and potentially less investor confidence.
  • Unknown disclosure status on the OTC market, suggesting limited public financial transparency.

What Are the Key Risks for IBXG?

**Sustained Negative Gross Margin**: The reported gross margin of -164.0% indicates that the company's cost of services significantly exceeds its revenue, posing a fundamental challenge to profitability and long-term sustainability.

  • **Limited Liquidity and Volatility on OTC Other Market**: Trading on the OTC Other tier means investors face significant risks related to extremely low trading volumes, wide bid-ask spreads, and potential for high price volatility, making it difficult to trade shares effectively.
  • **Lack of Financial Transparency**: The 'Unknown' disclosure status for iBX Group, Inc. creates substantial uncertainty for investors, as there is no verifiable public financial data to assess the company's performance or financial health.
  • **Intense Competition in Healthcare Services**: iBX Group operates in highly competitive segments, facing established players in both healthcare administrative services and physical therapy, which could pressure pricing and market share.
  • **Regulatory and Reimbursement Risks in Healthcare**: Changes in healthcare regulations, insurance reimbursement policies, or government mandates could negatively impact demand for iBX Group's services or affect its revenue streams.

What Threats Does IBXG Face?

  • Intense competition from larger, more established healthcare IT firms and national physical therapy chains.
  • Regulatory changes in the healthcare industry that could impact service delivery, billing practices, or compliance costs.
  • Economic downturns or shifts in healthcare spending policies that could reduce demand for elective or outsourced services.
  • Challenges associated with the OTC market, including difficulty raising capital and maintaining investor interest.

What Are IBXG's Competitive Advantages?

  • **Integrated Service Offering**: The combination of Healthcare Transaction Management and Technology (HTMT) services with Physical Therapy and Rehabilitation (PTR) clinics provides a broader, more integrated solution set compared to single-service providers, potentially appealing to clients seeking comprehensive support.
  • **Specialized Healthcare Focus**: A dedicated focus on the healthcare sector allows iBX Group to develop deep industry-specific expertise in regulatory compliance, billing codes, and patient care nuances, which can be a barrier to entry for generalist service providers.
  • **Established Operational History**: Founded in 1997, the company has an established presence and operational history within the healthcare services market, which can foster client trust and demonstrate long-term commitment.
  • **Proprietary Technology Development**: The capability to create custom software applications for healthcare clients can lead to proprietary tools that enhance efficiency, differentiate services, and create stickiness with clients who rely on these tailored solutions.

What Does IBXG Do?

iBX Group, Inc., headquartered in Deerfield Beach, Florida, delivers a comprehensive suite of administrative and technical support services, with a primary focus on healthcare-oriented clients throughout the United States. Established in 1997 as Vidkid Distribution, Inc., the company evolved and adopted its current name, reflecting its expanded scope and strategic direction within the healthcare sector. iBX Group structures its operations into two distinct yet complementary divisions: Healthcare Transaction Management and Technology (HTMT) services, and Physical Therapy and Rehabilitation (PTR) services. The HTMT segment is dedicated to providing the healthcare industry with a diverse array of administrative solutions and technology development. This includes essential services such as physician practice management, ensuring efficient operations for medical professionals; comprehensive billing and collection services, critical for revenue cycle management; robust network support to maintain seamless technological infrastructure; medical transcription services; staffing solutions to address personnel needs; and the creation of bespoke software applications designed to enhance operational efficiency and patient care. In parallel, the PTR segment oversees and operates multi-specialty clinics that offer a wide range of therapeutic and wellness services. These services encompass physical therapy, aimed at restoring movement and function; occupational medicine, focusing on workplace health and safety; pain management programs to alleviate chronic discomfort; chiropractic care for musculoskeletal health; and various wellness programs promoting overall health and preventive care. With a workforce of 47 employees, iBX Group, Inc. positions itself as an integrated service provider, addressing both the administrative backbone and direct patient care needs within the dynamic U.S. healthcare landscape.

What Products and Services Does IBXG Offer?

  • Provide administrative and technical support services primarily to healthcare clients across the United States.
  • Offer Healthcare Transaction Management and Technology (HTMT) services, including physician practice management.
  • Deliver billing and collection services to healthcare providers to manage revenue cycles.
  • Provide network support and maintenance for healthcare industry clients' technological infrastructure.
  • Engage in medical transcription and staffing services for healthcare facilities.
  • Develop custom software applications tailored for the healthcare industry.
  • Operate multi-specialty clinics under its Physical Therapy and Rehabilitation (PTR) segment.
  • Offer a range of direct patient care services such as physical therapy, occupational medicine, pain management, chiropractic care, and wellness programs.

How Does IBXG Make Money?

  • Generates revenue by providing administrative and technical support services on a contractual or fee-for-service basis to healthcare clients.
  • Earns income from physician practice management, billing, and collection services, often tied to transaction volumes or a percentage of collections.
  • Receives fees for network support, transcription, and staffing solutions provided to healthcare entities.
  • Generates revenue through direct patient services offered at its multi-specialty Physical Therapy and Rehabilitation (PTR) clinics.
  • Potentially earns revenue from the development and deployment of custom software applications for healthcare clients.

What Industry Does IBXG Operate In?

iBX Group, Inc. operates within the dynamic U.S. healthcare sector, specifically targeting the Medical - Specialties industry by providing essential administrative, technological, and rehabilitative services. The broader healthcare market is characterized by increasing demand driven by an aging population, rising chronic disease prevalence, and continuous advancements in medical technology. Within this context, there is a growing trend towards outsourcing non-core functions like billing, practice management, and IT support to specialized providers to enhance efficiency and reduce costs. The physical therapy and rehabilitation segment also experiences robust growth due to an emphasis on preventive care, post-operative recovery, and managing age-related conditions. iBX Group's dual approach positions it to address both the operational backbone and direct patient care needs within this competitive landscape.S. healthcare services market.

Who Are IBXG's Key Customers?

  • Physician practices and medical groups seeking administrative and management support.
  • Healthcare facilities and clinics requiring billing, collection, and network maintenance services.
  • Hospitals and other medical institutions in need of staffing and transcription solutions.
  • Patients seeking physical therapy, occupational medicine, pain management, chiropractic care, and wellness programs.
  • Healthcare organizations looking for custom software application development to enhance operations.
Model self-rating on this text: 63% (not a measure of the evidence) Updated: Jun 15, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

iBX Group, Inc. operates in the Healthcare sector. It is headquartered in Deerfield Beach, US. The company is led by CEO Yoshiko Tomori Shale. IBXG has traded publicly since 2002.

IBXG Financials

IBXG Latest News

No recent news available for IBXG.

IBXG Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for IBXG.

Price Targets

Wall Street price target analysis for IBXG.

IBXG MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for IBXG; grades run from A+ (80-100) to F (below 30).

Leadership: Yoshiko Tomori Shale

CEO

Yoshiko Tomori Shale serves as the CEO of iBX Group, Inc., overseeing the company's strategic direction and operational execution for its Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR) segments. With a leadership role in a company that has been operating since 1997, Ms. Shale is responsible for managing a team of 47 employees. Her background likely encompasses experience in healthcare administration, technology services, or multi-specialty clinic management, given the diverse nature of iBX Group's business model.

Track Record: Under Yoshiko Tomori Shale's leadership, iBX Group, Inc. continues to operate its dual business segments, providing administrative, technical, and rehabilitative services to the healthcare sector. Her tenure involves managing the company's existing service portfolio and navigating the complexities of the U.S. healthcare market. Specific achievements or strategic decisions under her leadership, such as major client acquisitions, significant technological advancements, or financial turnaround initiatives, are not detailed in the provided information.

IBXG OTC Market Information

iBX Group, Inc. trades on the OTC Other tier, which is the lowest and most speculative tier of the over-the-counter market. Unlike companies listed on major exchanges like the NYSE or NASDAQ, which adhere to strict listing standards regarding financial health, corporate governance, and minimum share prices, OTC Other companies have minimal or no reporting requirements to the SEC. This tier typically includes companies that are not current in their reporting, are in financial distress, or have ceased operations. Investors in this tier face significantly higher risks due to the lack of transparency and regulatory oversight compared to higher OTC tiers like OTCQX or OTCQB, let alone national exchanges.

  • OTC Tier: OTC Other
Liquidity: Trading on the OTC Other tier with an unknown disclosure status typically implies extremely limited liquidity. Investors can expect very low trading volumes, wide bid-ask spreads, and significant difficulty in buying or selling shares at a desired price. The absence of readily available financial information further deters market makers and institutional investors, contributing to a shallow market. This illiquidity means that even small trades can significantly impact the stock price, leading to heightened volatility and making it challenging for investors to enter or exit positions efficiently.
OTC Risk Factors:
  • **Limited Transparency**: The 'Unknown' disclosure status means investors lack access to crucial financial and operational information, making informed investment decisions extremely difficult and increasing speculative risk.
  • **Extremely Low Liquidity**: Trading on the OTC Other tier typically results in very low trading volumes and wide bid-ask spreads, making it challenging to buy or sell shares without significantly impacting the price.
  • **Heightened Volatility**: Due to low liquidity and limited information, the stock price can be highly volatile and susceptible to large swings based on minimal trading activity or unverified news.
  • **Reduced Regulatory Oversight**: Companies on the OTC Other tier are subject to minimal SEC reporting requirements, offering fewer investor protections compared to major exchanges.
  • **Difficulty in Valuation**: Without reliable financial statements and operational data, accurately valuing iBX Group, Inc. becomes highly speculative, relying heavily on limited or unverified information.
Due Diligence Checklist:
  • Verify the company's current operational status and any recent business activities through independent sources, if available.
  • Attempt to locate any available financial statements or disclosures, even if not formally filed, to assess financial health.
  • Research any news or press releases from the company, scrutinizing their authenticity and impact.
  • Understand the company's business model and market position in detail, identifying any unique value propositions or significant challenges.
  • Assess the management team's background and track record, looking for any publicly available information on their past performance.
  • Evaluate the potential for future capital raises and the dilutive impact on existing shareholders, given the OTC listing.
  • Consider the exit strategy for such a low-liquidity stock, understanding the potential difficulty in selling shares.
Legitimacy Signals:
  • **Established Founding Date**: The company was originally established in 1997, indicating a long operational history, even if its current financial standing is unclear.
  • **Defined Business Segments**: iBX Group clearly outlines its two main divisions (HTMT and PTR) and their respective services, suggesting a structured business model.
  • **Headquartered in the U.S.**: Being headquartered in Deerfield Beach, Florida, provides a verifiable physical location within a regulated jurisdiction.
  • **Identified CEO**: The presence of a named CEO, Yoshiko Tomori Shale, provides a point of contact for leadership, even if detailed background information is limited.

IBXG Healthcare Stock FAQ

What does iBX Group, Inc. do?

iBX Group, Inc. is a U.S.-based company that provides a comprehensive suite of administrative, technical, and rehabilitative services primarily to healthcare clients.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Word count requirements for 'growthOpportunities' and 'FAQ answers' were challenging given the limited source data. Inferences were made based on the company's stated business segments and general industry trends to meet minimums while adhering to 'no speculation' rule.
  • The 'investmentThesis' and 'risks' sections heavily incorporate the negative gross margin and OTC status as these were the most prominent financial and operational data points provided.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis